DOI: 10.1055/s-00000069

Seminars in Liver Disease

References

Pollack Jr CV, Reilly PA, van Ryn J. , et al.
Idarucizumab for dabigatran reversal - full cohort analysis.

N Engl J Med 2017;
377 (05) 431-441

Download Bibliographical Data

Access:
Access: